ModivCare (MODV) Stock Forecast, Price Target & Predictions
MODV Stock Forecast
ModivCare stock forecast is as follows: an average price target of $38.67 (represents a 173.87% upside from MODV’s last price of $14.12) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
MODV Price Target
The average price target for ModivCare (MODV) is $38.67 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $50.00 to $16.00. This represents a potential 173.87% upside from MODV's last price of $14.12.
MODV Analyst Ratings
According to 2 Wall Street analysts, ModivCare's rating consensus is 'Buy'. The analyst rating breakdown for MODV stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
ModivCare Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 06, 2024 | Brooks O'Neil | Lake Street | $50.00 | $27.00 | 85.19% | 254.11% |
| Apr 02, 2024 | Brooks O'Neil | Loop Capital Markets | $50.00 | $20.78 | 140.62% | 254.11% |
| Feb 23, 2024 | Robbie Marcus | J.P. Morgan | $16.00 | $30.89 | -48.20% | 13.31% |
The latest ModivCare stock forecast, released on May 06, 2024 by Brooks O'Neil from Lake Street, set a price target of $50.00, which represents a 85.19% increase from the stock price at the time of the forecast ($27.00), and a 254.11% increase from MODV last price ($14.12).
ModivCare Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 3 |
| Avg Price Target | - | - | $38.67 |
| Last Closing Price | $14.12 | $14.12 | $14.12 |
| Upside/Downside | -100.00% | -100.00% | 173.87% |
In the current month, the average price target of ModivCare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to ModivCare's last price of $14.12. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 06, 2024 | Lake Street | - | Buy | Upgrade |
| Aug 03, 2022 | Stephens | - | Overweight | Initialise |
ModivCare's last stock rating was published by Lake Street on May 06, 2024. The company Upgrade its MODV rating from "null" to "Buy".
ModivCare Financial Forecast
ModivCare Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $686.92M | $699.11M | $662.31M | $653.92M | $647.78M | - | $574.48M | $575.77M | $493.06M | $474.45M | $453.61M | $398.51M | $320.62M | $282.26M | $367.29M | $384.83M | $393.38M | $363.91M | $367.81M |
| Avg Forecast | $770.91M | $757.31M | $744.98M | $736.87M | $727.11M | $712.55M | $701.00M | $663.86M | $696.78M | $698.68M | $653.87M | $628.40M | $618.42M | $593.47M | $583.30M | $565.77M | $553.33M | $499.60M | $486.95M | $486.32M | $395.50M | $341.98M | $368.06M | $386.20M | $378.80M | $364.40M | $364.40M | $356.90M |
| High Forecast | $778.61M | $764.87M | $752.42M | $744.23M | $734.37M | $716.25M | $708.00M | $670.49M | $701.57M | $713.43M | $660.40M | $634.68M | $624.60M | $599.39M | $583.30M | $579.40M | $566.66M | $511.63M | $498.68M | $498.03M | $405.02M | $350.22M | $376.93M | $395.50M | $387.92M | $373.18M | $373.18M | $365.50M |
| Low Forecast | $751.33M | $738.07M | $726.06M | $718.15M | $708.63M | $709.47M | $683.19M | $647.00M | $693.93M | $682.08M | $637.25M | $612.44M | $602.71M | $578.39M | $583.30M | $549.53M | $537.45M | $485.26M | $472.97M | $472.36M | $384.15M | $332.17M | $357.50M | $375.12M | $367.93M | $353.94M | $353.94M | $346.66M |
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.98% | 1.07% | 1.05% | 1.06% | 1.09% | - | 1.02% | 1.04% | 0.99% | 0.97% | 0.93% | 1.01% | 0.94% | 0.77% | 0.95% | 1.02% | 1.08% | 1.00% | 1.03% |
ModivCare's average Quarter revenue forecast for Dec 23 based on 3 analysts is $696.78M, with a low forecast of $693.93M, and a high forecast of $701.57M. MODV's average Quarter revenue forecast represents a 1.43% increase compared to the company's last Quarter revenue of $686.92M (Sep 23).
ModivCare EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | $41.28M | $-147.24M | $33.79M | $32.66M | $38.12M | - | $38.82M | $4.26M | $18.88M | $39.57M | $45.52M | $26.42M | $60.84M | $59.08M | $11.08M | $-6.67M | $17.59M | $1.55M | $5.59M |
| Avg Forecast | $48.76M | $47.90M | $47.12M | $46.61M | $45.99M | $45.07M | $44.34M | $42.90M | $44.07M | $44.19M | $41.36M | $39.00M | $39.12M | $17.69M | $36.89M | $35.46M | $2.58M | $16.08M | $24.41M | $36.41M | $35.80M | $21.63M | $23.28M | $24.43M | $23.96M | $23.05M | $23.05M | $22.57M |
| High Forecast | $49.25M | $48.38M | $47.59M | $47.07M | $46.45M | $45.30M | $44.78M | $51.48M | $44.38M | $45.13M | $41.77M | $46.80M | $39.51M | $21.23M | $36.89M | $42.55M | $3.10M | $19.30M | $29.29M | $43.70M | $42.97M | $22.15M | $23.84M | $25.02M | $24.54M | $23.60M | $23.60M | $23.12M |
| Low Forecast | $47.52M | $46.68M | $45.92M | $45.42M | $44.82M | $44.88M | $43.21M | $34.32M | $43.89M | $43.14M | $40.31M | $31.20M | $38.12M | $14.15M | $36.89M | $28.36M | $2.07M | $12.87M | $19.53M | $29.13M | $28.64M | $21.01M | $22.61M | $23.73M | $23.27M | $22.39M | $22.39M | $21.93M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.93% | -3.56% | 0.87% | 0.83% | 2.15% | - | 1.09% | 1.65% | 1.17% | 1.62% | 1.25% | 0.74% | 2.81% | 2.54% | 0.45% | -0.28% | 0.76% | 0.07% | 0.25% |
3 analysts predict MODV's average Quarter EBITDA for Dec 23 to be $44.07M, with a high of $44.38M and a low of $43.89M. This is 6.77% upper than ModivCare's previous annual EBITDA (Sep 23) of $41.28M.
ModivCare Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | $-4.30M | $-190.94M | $-5.99M | $-5.00M | $-2.06M | - | $-165.00K | $6.79M | $-7.57M | $13.67M | $18.84M | $-3.06M | $38.80M | $37.00M | $16.10M | $-6.06M | $8.15M | $-1.71M | $582.00K |
| Avg Forecast | $20.00M | $18.15M | $14.50M | $13.08M | $17.26M | $12.39M | $10.88M | $347.11K | $18.17M | $15.82M | $23.04M | $315.55K | $22.11M | $-7.10M | $20.21M | $286.87K | $-21.99M | $-6.45M | $8.43M | $15.07M | $-4.15M | $20.15M | $4.73M | $3.97M | $709.35K | $6.53M | $2.84M | $4.97M |
| High Forecast | $20.26M | $18.39M | $14.69M | $13.25M | $17.49M | $17.43M | $11.02M | $416.53K | $21.30M | $23.09M | $23.34M | $378.66K | $22.40M | $-5.68M | $20.21M | $344.24K | $-17.59M | $-5.16M | $10.12M | $18.09M | $-3.32M | $20.78M | $4.88M | $4.10M | $731.57K | $6.73M | $2.93M | $5.12M |
| Low Forecast | $19.34M | $17.55M | $14.02M | $12.65M | $16.69M | $7.22M | $10.52M | $277.69K | $14.00M | $10.41M | $22.28M | $252.44K | $21.38M | $-8.51M | $20.21M | $229.49K | $-26.39M | $-7.74M | $6.75M | $12.06M | $-4.98M | $19.39M | $4.55M | $3.82M | $682.89K | $6.28M | $2.73M | $4.78M |
| Surprise % | - | - | - | - | - | - | - | - | - | -0.27% | -8.29% | -18.97% | -0.23% | 0.29% | - | -0.58% | -0.31% | 1.17% | 1.62% | 1.25% | 0.74% | 1.93% | 7.82% | 4.05% | -8.54% | 1.25% | -0.60% | 0.12% |
ModivCare's average Quarter net income forecast for Mar 22 is $286.87K, with a range of $229.49K to $344.24K. MODV's average Quarter net income forecast represents a -95.77% decrease compared to the company's last Quarter net income of $6.79M (Dec 21).
ModivCare SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | $70.14M | $79.24M | $79.71M | $90.06M | $75.89M | - | $76.81M | $92.00M | $68.05M | $56.35M | $54.87M | $54.10M | $34.44M | $31.20M | $20.80M | $15.00M | $15.98M | $16.86M | $19.40M |
| Avg Forecast | $80.55M | $79.12M | $77.84M | $76.99M | $75.97M | $74.45M | $73.24M | $83.84M | $72.80M | $73.00M | $68.32M | $76.22M | $64.61M | $63.79M | $60.94M | $69.29M | $64.17M | $57.99M | $34.76M | $43.90M | $73.33M | $35.73M | $38.46M | $40.35M | $39.58M | $38.07M | $38.07M | $37.29M |
| High Forecast | $81.35M | $79.91M | $78.61M | $77.76M | $76.73M | $74.83M | $73.97M | $100.61M | $73.30M | $74.54M | $69.00M | $91.46M | $65.26M | $76.55M | $60.94M | $83.15M | $77.00M | $69.59M | $41.71M | $52.68M | $87.99M | $36.59M | $39.38M | $41.32M | $40.53M | $38.99M | $38.99M | $38.19M |
| Low Forecast | $78.50M | $77.11M | $75.86M | $75.03M | $74.04M | $74.13M | $71.38M | $67.07M | $72.50M | $71.26M | $66.58M | $60.97M | $62.97M | $51.03M | $60.94M | $55.43M | $51.34M | $46.39M | $27.81M | $35.12M | $58.66M | $34.71M | $37.35M | $39.19M | $38.44M | $36.98M | $36.98M | $36.22M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.96% | 1.16% | 1.05% | 1.39% | 1.19% | - | 1.11% | 1.43% | 1.17% | 1.62% | 1.25% | 0.74% | 0.96% | 0.81% | 0.52% | 0.38% | 0.42% | 0.44% | 0.52% |
ModivCare's average Quarter SG&A projection for Dec 23 is $72.80M, based on 3 Wall Street analysts, with a range of $72.50M to $73.30M. The forecast indicates a 3.79% rise compared to MODV last annual SG&A of $70.14M (Sep 23).
ModivCare EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | $-0.30 | $-13.47 | $-0.42 | $-0.35 | $-0.15 | - | $-0.01 | $0.48 | $-0.54 | $0.97 | $1.33 | $-0.22 | $2.52 | $-0.98 | $1.00 | $-0.55 | $0.47 | $-0.22 | $-0.04 |
| Avg Forecast | $1.41 | $1.28 | $1.02 | $0.92 | $1.21 | $0.87 | $0.77 | $0.27 | $1.28 | $1.11 | $1.62 | $1.49 | $1.56 | $1.62 | $1.42 | $1.43 | $1.62 | $1.42 | $1.28 | $1.60 | $1.52 | $1.42 | $0.33 | $0.28 | $0.05 | $0.46 | $0.20 | $0.35 |
| High Forecast | $1.42 | $1.29 | $1.03 | $0.93 | $1.23 | $1.23 | $0.78 | $0.27 | $1.50 | $1.62 | $1.64 | $1.51 | $1.58 | $1.64 | $1.42 | $1.48 | $1.68 | $1.46 | $1.33 | $1.65 | $1.57 | $1.46 | $0.34 | $0.29 | $0.05 | $0.47 | $0.21 | $0.36 |
| Low Forecast | $1.36 | $1.23 | $0.99 | $0.89 | $1.17 | $0.51 | $0.74 | $0.26 | $0.98 | $0.73 | $1.57 | $1.44 | $1.50 | $1.57 | $1.42 | $1.38 | $1.56 | $1.36 | $1.24 | $1.54 | $1.46 | $1.37 | $0.32 | $0.27 | $0.05 | $0.44 | $0.19 | $0.34 |
| Surprise % | - | - | - | - | - | - | - | - | - | -0.27% | -8.31% | -0.28% | -0.23% | -0.09% | - | -0.01% | 0.30% | -0.38% | 0.75% | 0.83% | -0.14% | 1.77% | -2.94% | 3.57% | -11.00% | 1.02% | -1.10% | -0.11% |
According to 1 Wall Street analysts, ModivCare's projected average Quarter EPS for Mar 22 is $1.43, with a low estimate of $1.38 and a high estimate of $1.48. This represents a 198.67% increase compared to MODV previous annual EPS of $0.48 (Dec 21).
ModivCare Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| MODV | ModivCare | $14.12 | $38.67 | 173.87% | Buy |
| MD | Pediatrix Medical Group | $10.93 | $18.40 | 68.34% | Hold |
| HCSG | Healthcare Services Group | $11.14 | $17.33 | 55.57% | Hold |
| SGRY | Surgery Partners | $31.00 | $47.50 | 53.23% | Buy |
| EHAB | Enhabit | $8.10 | $10.25 | 26.54% | Hold |
| SEM | Select Medical | $35.23 | $40.00 | 13.54% | Buy |
| INNV | InnovAge | $5.99 | $6.80 | 13.52% | Hold |
| EHC | Encompass Health | $93.25 | $93.17 | -0.09% | Buy |
| PNTG | Pennant Group | $34.52 | $30.67 | -11.15% | Buy |
| ENSG | Ensign Group | $152.73 | $114.25 | -25.19% | Buy |
MODV Forecast FAQ
Is ModivCare a good buy?
Yes, according to 2 Wall Street analysts, ModivCare (MODV) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of MODV's total ratings.
What is MODV's price target?
ModivCare (MODV) average price target is $38.67 with a range of $16 to $50, implying a 173.87% from its last price of $14.12. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will ModivCare stock go up soon?
According to Wall Street analysts' prediction for MODV stock, the company can go up by 173.87% (from the last price of $14.12 to the average price target of $38.67), up by 254.11% based on the highest stock price target, and up by 13.31% based on the lowest stock price target.
Can ModivCare stock reach $20?
MODV's average twelve months analyst stock price target of $38.67 supports the claim that ModivCare can reach $20 in the near future.
What are ModivCare's analysts' financial forecasts?
ModivCare's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $2.8B (high $2.83B, low $2.75B), average EBITDA is $178.3M (high $188.02M, low $167.23M), average net income is $40.88M (high $46.35M, low $34.71M), average SG&A $307.5M (high $326.14M, low $286.62M), and average EPS is $3.12 (high $3.5, low $2.68). MODV's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $3.01B (high $3.04B, low $2.93B), average EBITDA is $190.39M (high $192.29M, low $185.55M), average net income is $65.73M (high $66.58M, low $63.56M), average SG&A $314.5M (high $317.64M, low $306.51M), and average EPS is $4.62 (high $4.68, low $4.47).
Did the MODV's actual financial results beat the analysts' financial forecasts?
Based on ModivCare's last annual report (Dec 2022), the company's revenue was $2.5B, beating the average analysts forecast of $2.36B by 6.08%. Apple's EBITDA was $157.5M, beating the average prediction of $129.16M by 21.94%. The company's net income was $-1.842M, missing the average estimation of $35.51M by -105.19%. Apple's SG&A was $322.17M, beating the average forecast of $258.63M by 24.57%. Lastly, the company's EPS was $-0.13, missing the average prediction of $6.03 by -102.16%. In terms of the last quarterly report (Sep 2023), ModivCare's revenue was $686.92M, missing the average analysts' forecast of $698.68M by -1.68%. The company's EBITDA was $41.28M, missing the average prediction of $44.19M by -6.59%. ModivCare's net income was $-4.302M, missing the average estimation of $15.82M by -127.19%. The company's SG&A was $70.14M, missing the average forecast of $73M by -3.91%. Lastly, the company's EPS was $-0.3, missing the average prediction of $1.11 by -126.95%